We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksForterra Regulatory News (FORT)

Share Price Information for Forterra (FORT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 162.60
Bid: 161.00
Ask: 161.40
Change: 2.60 (1.63%)
Spread: 0.40 (0.248%)
Open: 160.00
High: 163.60
Low: 160.00
Prev. Close: 160.00
FORT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Chief Executive Officer

22 Nov 2022 07:01

RNS Number : 1300H
Forterra plc
22 November 2022
 

22 November 2022

 

FORTERRA PLC

 

Appointment of Chief Executive Officer

 

The Board of Forterra plc ("Forterra") is pleased to announce that Neil Ash will become Chief Executive Officer designate of Forterra on 3 April 2023. This appointment follows the announcement on 24 May 2022 that Stephen Harrison would be stepping down as Chief Executive Officer ("CEO") during the first half of 2023, allowing time both to commission the new Desford brick factory and support an orderly transition.

 

Neil has almost three decades' experience in the building materials sector and an impressive track record of improving performance and delivering growth. Currently at Etex, the Belgian lightweight building materials manufacturer, he leads the Building Performance division which is a €2 billion revenue business. During his time at Etex Neil oversaw major capex projects, significant acquisitions, and developed its sales approach which delivered strong top line growth.

 

His experience includes 15 years at Lafarge, where he undertook many roles, including the role of Vice President International Business Development and Sales and Commercial Director UK & Ireland of Lafarge Plasterboard.

 

Justin Atkinson, Chairman, commented:

 

"We are very pleased to appoint Neil as the next CEO. His business leadership and extensive building materials sector knowledge will be invaluable to Forterra in the next stages of our development and the Board looks forward to working with him.

 

The Board and I are grateful to Stephen Harrison for the significant contribution he has made to the business during his tenure as CEO. We wish him all the best for the future after he leaves Forterra in the second quarter of 2023."

 

Regulatory Disclosures 

This announcement is made pursuant to the Company's obligations under Listing Rule 9.6.11(1)R.

The Company will disclose details of exit arrangements for Stephen Harrison on its website in due course, in accordance with its statutory obligations.

 

There is no further information to be disclosed under Listing Rule 9.6.13R.

 

This announcement contains inside information for the purposes of article 7 of the Market Abuse Regulation (EU) No 596/2014.

 

Remuneration Arrangements

Neil's service agreement, remuneration and benefits will be consistent with Forterra's Remuneration Policy as approved by shareholders at the AGM in May 2020. 

 

ENQUIRIES

 

FTI Consulting +44 203 727 1340

Richard Mountain / Nick Hasell

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABBBLTMTJTBMT
Date   Source Headline
15th Apr 20241:46 pmRNSAnnual Report & Accounts 2023 & Notice of AGM 2024
12th Apr 202412:09 pmRNSDirector/PDMR Shareholding
9th Apr 20244:22 pmRNSDirector/PDMR Shareholding
9th Apr 20244:19 pmRNSDirector/PDMR Shareholding
3rd Apr 20242:19 pmRNSDirector/PDMR Shareholding
27th Mar 20244:44 pmRNSDirector/PDMR Shareholding
25th Jan 202412:27 pmRNSDirector Declaration
24th Jan 20247:19 amRNSProgressive publish new research
24th Jan 20247:00 amRNS2023 Trading Update
23rd Jan 20247:00 amRNSHolding(s) in Company
8th Dec 20237:00 amRNSDirector Declaration
9th Nov 20237:00 amRNSAppointment of Joint Corporate Broker
20th Oct 20236:05 pmRNSDirector/PDMR Shareholding
11th Oct 20237:00 amRNSQ3 Trading Update
5th Oct 20235:04 pmRNSGrant of Options under 2023 SAYE Scheme
11th Sep 20237:00 amRNSHolding(s) in Company
1st Sep 20235:46 pmRNSHolding(s) in Company
23rd Aug 20233:59 pmRNSHolding(s) in Company
27th Jul 20237:00 amRNSSix months ended 30 June 2023
11th Jul 20237:00 amRNSPost close half year trading update
5th Jul 202312:39 pmRNSEmployee Benefit Trust Share Purchase
30th Jun 20231:51 pmRNSHolding(s) in Company
6th Jun 202312:57 pmRNSEmployee Benefit Trust Share Purchase
23rd May 20232:22 pmRNSAnnual General Meeting 2023 Results
18th May 202312:12 pmRNSProgressive publish new research
16th May 20237:00 amRNSPre-AGM trading update
5th May 20234:39 pmRNSDirector/PDMR Shareholding
4th May 20239:00 amRNSEmployee Benefit Trust Share Purchase
25th Apr 20237:00 amRNSNotification of Board Changes
11th Apr 20234:15 pmRNSPCA Shareholdings
4th Apr 20231:12 pmRNSEmployee Benefit Trust Share Purchase
3rd Apr 20232:03 pmRNSGrant under Performance Share Plan
29th Mar 202310:21 amRNSAnnual Report & Accounts 2022 & Notice of AGM 2023
16th Mar 20235:28 pmRNSGrant under Deferred Annual Bonus Plan
10th Mar 20239:18 amRNSProgressive publishes new research
9th Mar 20237:02 amRNSAppointment of Independent Non-Executive Director
9th Mar 20237:00 amRNSFull Year Results
3rd Mar 20232:18 pmRNSEmployee Benefit Trust Share Purchase
3rd Feb 202310:13 amRNSEmployee Benefit Trust Share Purchase
1st Feb 20238:18 amRNSDirector Declaration
25th Jan 20237:00 amRNSTrading Update
5th Jan 20233:12 pmRNSEmployee Benefit Trust Share Purchase
14th Dec 20225:10 pmRNSEmployee Benefit Trust Share Purchase
8th Dec 20227:00 amRNSHolding(s) in Company
2nd Dec 20224:10 pmRNSEmployee Benefit Trust Share Purchase
22nd Nov 20227:54 amRNSProgressive publishes new research
22nd Nov 20227:01 amRNSAppointment of Chief Executive Officer
22nd Nov 20227:00 amRNSTrading Update
4th Nov 20222:50 pmRNSEmployee Benefit Trust Share Purchase
2nd Nov 20228:45 amRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.